Eastgate Competitors

Delisted . USA . 
Stock . Eastgate Biotech Corp
ETBIDelisted Stock  USD 0  0.00  0.00%   
Eastgate Biotech Corp competes with ICC Holdings, Jacobs Solutions, GoHealth, NI Holdings, and Siriuspoint; as well as few others. The company conducts business under Healthcare sector and is part of Pharmaceuticals industry. Analyzing Eastgate Biotech competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Eastgate Biotech to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Eastgate Biotech competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.000.010.01
Details
Intrinsic
Valuation
LowRealHigh
0.0000.00
Details
Naive
Forecast
LowNextHigh
000
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
-0.002400.01
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Eastgate Biotech. Your research has to be compared to or analyzed against Eastgate Biotech's peers to derive any actionable benefits. When done correctly, Eastgate Biotech's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Eastgate Biotech Corp.

Eastgate Biotech Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Eastgate Biotech and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of Eastgate and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Eastgate Biotech Corp does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between Eastgate Stock performing well and Eastgate Biotech Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Eastgate Biotech's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Eastgate Biotech Competitive Analysis

The better you understand Eastgate Biotech competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Eastgate Biotech's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Eastgate Biotech's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
ETBI ICCH J GOCO NODK SPNT ELVA ALDFU
 0.00 
 0 
Eastgate
 0.26 
 23.22 
ICC
 0.71 
 135.12 
Jacobs
 3.67 
 11.30 
GoHealth
 0.35 
 16.95 
NODK
 1.81 
 15.76 
Siriuspoint
 1.94 
 2.53 
Electrovaya
 0.20 
 10.01 
Aldel
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Very steady
Somewhat reliable
Very steady
Not too volatile
Relatively risky
Very steady
Market Performance
(90 Days Performance)
Very Weak
Insignificant
Good
Good
OK
OK
OK
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
Low
Low
Below Average
Below Average
Very Low
High
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Fairly Valued
Under Valued
Under Valued
Fairly Valued
Fairly Valued
Under Valued
Fairly Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Buy
Strong Buy
Strong Sell
Strong Sell
Strong Buy
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Current Ratio
0.02 X
0.51 X
1.43 X
1.83 X
0.51 X
3.31 X
N/A
N/A
Net Asset
N/A
211.02 M
11.76 B
1.5 B
615.68 M
12.87 B
36.51 M
N/A
Profit Margin
N/A
0.07 %
0.04 %
(0.04) %
(0.02) %
0.12 %
0.01 %
N/A
EBITDA
(3.55 M)
6.47 M
1.26 B
38.67 M
1.03 M
393.9 M
1.06 M
N/A
Operating Margin
(74.40) %
0.11 %
0.07 %
(0.35) %
(0.04) %
0.21 %
(0.06) %
N/A
Current Valuation
18.92 M
72.63 M
17.74 B
648.46 M
305.94 M
2.77 B
113.27 M
N/A
Price To Book
N/A
0.94 X
3.71 X
0.51 X
1.43 X
1.02 X
12.27 X
N/A
Retained Earnings
(14.63 M)
47.84 M
2.37 B
(420.28 M)
208.38 M
601 M
(130.45 M)
N/A
Current Asset
167 K
N/A
3.67 B
N/A
44.43 M
N/A
N/A
N/A
Five Year Return
N/A
N/A
0.78 %
N/A
N/A
N/A
N/A
N/A
Beta
-3039.35
0.32
0.7
1.65
0.36
0.95
1.38
N/A
Number Of Employees
2
105
60 K
2.53 K
219
999
97
N/A
Shares Outstanding
2.06 B
2.96 M
123.97 M
10.13 M
20.65 M
161.87 M
34.13 M
N/A
Cash Flow From Operations
(389.48 K)
8.52 M
1.05 B
109.14 M
25.97 M
581.3 M
(4.86 M)
N/A
Annual Yield
N/A
N/A
0.01 %
N/A
N/A
N/A
N/A
N/A
Total Debt
1.67 M
15 M
2.75 B
592.35 M
2.06 M
786.2 M
19.03 M
N/A
Return On Equity
N/A
0.0968
0.0933
-0.16
-0.0361
0.13
0.087
N/A
Book Value Per Share
(0) X
24.67 X
53.25 X
20.95 X
11.69 X
15.41 X
0.22 X
N/A
Return On Asset
N/A
0.024
0.0498
-0.0276
-0.0013
0.0206
0.0318
N/A
Number Of Shares Shorted
N/A
2.07 K
1.39 M
187.91 K
26.06 K
2.04 M
57.75 K
N/A
Current Liabilities
2.11 M
N/A
2.56 B
N/A
4.38 M
N/A
N/A
N/A
Total Asset
N/A
211.02 M
11.76 B
1.5 B
615.68 M
12.87 B
36.51 M
N/A
Debt To Equity
N/A
0.24 %
0.66 %
0.97 %
0.64 %
0.37 %
N/A
N/A
Short Ratio
N/A
1.00 X
1.70 X
5.12 X
0.84 X
3.76 X
1.91 X
N/A
Target Price
N/A
N/A
152.01
18.75
N/A
N/A
7.2
N/A
Shares Owned By Institutions
N/A
24.78 %
86.57 %
54.14 %
24.23 %
88.21 %
9.30 %
N/A
Market Capitalization
205.75 K
68.62 M
16.88 B
246.23 M
349.17 M
2.55 B
93.19 M
N/A
Price To Earning
(0.10) X
13.21 X
38.39 X
25.59 X
7.34 X
3.25 X
N/A
N/A
Price To Earnings To Growth
N/A
N/A
1.65 X
(0.02) X
N/A
(0.25) X
N/A
N/A
Price To Sales
1.49 X
0.74 X
1.00 X
0.36 X
0.89 X
0.94 X
1.88 X
N/A
Net Income
(2.98 M)
4.26 M
852.64 M
(151.27 M)
(5.48 M)
363.7 M
(1.47 M)
N/A
Earnings Per Share
(0.01) X
2.16 X
4.79 X
(3.29) X
(0.43) X
1.60 X
0.02 X
N/A
Shares Owned By Insiders
N/A
54.53 %
1.00 %
14.86 %
67.56 %
10.62 %
33.80 %
N/A
Revenue
N/A
82.94 M
11.5 B
734.67 M
365.69 M
2.74 B
43.37 M
N/A
Working Capital
(1.94 M)
N/A
1.27 B
106.43 M
40.05 M
N/A
(705 K)
N/A
Cash And Equivalents
4.91 K
8.04 M
1.14 B
215.4 M
63.03 M
4.34 B
N/A
N/A
Cash Per Share
N/A
2.63 X
8.64 X
24.23 X
2.98 X
27.15 X
N/A
N/A
Gross Profit
N/A
250.99 K
3.5 B
444 M
(69.03 M)
(129.2 M)
4.89 M
N/A
Day Typical Price
0.0045
23.2
135.44
11.46
16.96
15.63
2.55
10.0
Accumulation Distribution
N/A
0.0026
0.0071
2141.41
410.72
19177.86
0.0194
89.52
Market Facilitation Index
N/A
0.06
0.96
0.0
0.0
0.0
0.05
N/A
Daily Balance Of Power
0.0
1.0
(1.00)
(0.67)
(0.15)
0.6087
(1.00)
1.0
Period Momentum Indicator
N/A
0.06
(0.96)
(0.43)
(0.06)
0.28
(0.05)
0.02
Rate Of Daily Change
1.0
1.0
0.99
0.96
1.0
1.02
0.98
1.0
Day Median Price
0.0045
23.19
135.6
11.54
16.96
15.56
2.55
10.0
Price Action Indicator
N/A
0.06
(0.96)
(0.45)
(0.04)
0.34
(0.05)
0.02
Relative Strength Index
N/A
58.0
52.88
53.76
54.15
71.12
72.63
N/A
Coefficient Of Variation
841.33
2358.2
767.72
557.77
717.07
1307.0
834.34
202954.41
Mean Deviation
131.38
0.3046
1.03
3.36
1.09
1.31
2.64
0.0648
Jensen Alpha
71.43
0.0143
0.0662
0.7743
0.1355
(0.05)
0.3426
(0.01)
Total Risk Alpha
(21.46)
(0.07)
(0.05)
0.0768
(0.04)
(0.17)
(0.16)
(0.03)
Sortino Ratio
N/A
(0.18)
0.0416
0.1798
0.0455
0.0163
0.1071
(1.04)
Downside Variance
N/A
0.3302
2.99
11.94
1.99
3.18
9.54
0.0144
Standard Deviation
542.05
0.4929
1.51
4.16
1.35
2.01
3.8
0.1016
Kurtosis
65.92
3.92
4.75
(0.41)
(0.02)
9.89
3.98
1.58
Potential Upside
N/A
0.8261
2.41
8.03
2.09
2.68
6.47
0.2004
Treynor Ratio
(1.05)
(0.37)
0.1774
(2.19)
0.4743
0.0828
0.4962
(1.78)
Maximum Drawdown
97.78
3.36
9.97
17.48
6.11
13.03
20.02
0.4006
Variance
293816.92
0.2429
2.27
17.31
1.83
4.03
14.43
0.0103
Market Risk Adjusted Performance
(1.04)
(0.36)
0.1874
(2.18)
0.4843
0.0928
0.5062
(1.77)
Risk Adjusted Performance
0.0958
0.026
0.0993
0.1378
0.1054
0.0617
0.0947
(0.06)
Skewness
8.12
0.0016
(1.07)
0.286
(0.28)
1.53
1.33
0.9266
Semi Deviation
N/A
0.4119
1.49
3.08
1.29
1.62
2.64
0.0703
Information Ratio
0.1186
(0.21)
0.0478
0.1494
0.0475
0.0145
0.0871
(1.22)
Value At Risk
N/A
(0.60)
(1.47)
(5.47)
(2.04)
(2.74)
(4.05)
(0.10)
Expected Short fall
N/A
(0.39)
(1.05)
(4.08)
(1.16)
(1.46)
(3.17)
(0.16)
Downside Deviation
N/A
0.5746
1.73
3.46
1.41
1.78
3.09
0.1202
Semi Variance
N/A
0.1697
2.21
9.49
1.65
2.64
6.97
0.0049

Eastgate Biotech Competition Performance Charts

Five steps to successful analysis of Eastgate Biotech Competition

Eastgate Biotech's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Eastgate Biotech Corp in relation to its competition. Eastgate Biotech's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Eastgate Biotech in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Eastgate Biotech's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Eastgate Biotech Corp, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Eastgate Biotech position

In addition to having Eastgate Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Materials ETFs Thematic Idea Now

Materials ETFs
Materials ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Materials ETFs theme has 51 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Materials ETFs Theme or any other thematic opportunities.
View All  Next Launch
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Consideration for investing in Eastgate Stock

If you are still planning to invest in Eastgate Biotech Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eastgate Biotech's history and understand the potential risks before investing.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY